Joseph H. C. Lai1, Jiaxin Liu2, Jianpan Huang1, Yang Liu1, Zilin Chen1, Peng Xiao1, Gilberto K. K. Leung2, and Kannie W. Y. Chan1,3,4
1Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, Hong Kong, 2Division of Neurosurgery, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, 3Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 4City University of Hong Kong Shenzhen Research Institute, Shenzhen, China
Synopsis
CEST MRI in hematoma could be challenging depending on the
involvement of iron. This study examined the feasibility of CEST in monitoring
ICH and its progression over two weeks. The AREX data supported that the
iron-overloading pathology might not significantly attenuate CEST contrast
as demonstrated both in vitro and in vivo at 3T. We observed the most
significant decrease in rNOE (37%) and APT (47%)
contrast in lesions were on day7 and day3, respectively, when compared to contralateral
side. This could indicate neuropathologies related to lipid and amide, which
could be valuable for ICH diagnosis and treatment planning at 3T.
Introduction
ICH, which is caused by the rupture of blood vessels in
brain, is a devastating subtype of stroke.1 The ICH treatment remains challenging because of limited approaches to detect pathophysiological
changes in brain.2 Monitoring the molecular changes in hematoma and its progression could provide
essential information for diagnosis and therapy. CEST has been applied to study
ischemic stroke, in particular to image the pH and to identify penumbra.3-5 ICH is a different animal model. A study has compared the APT signal between
ischemic and hemorrhagic stroke.6 Yet, the underlying molecular
changes remain to be identified.
In this study, CEST
was used to monitor the pathophysiological changes of an ICH mouse model over
two weeks. Changes of APT and rNOE contrast were studied during hematoma
progression. Since iron overload has been reported as a pathology of ICH,7 the CEST contrast might be affected in the presence of iron at 11.7T.8 Therefore, we also studied a set of iron-containing phantom to determine the
iron level that will not attenuate the CEST contrast.Methods
Five male C57BL/6 mice (8 weeks, Jackson Laboratory) were acquired for the experiment. ICH induction procedures were modified
from a reported protocol.9 0.3uL collagenase (Type IV-S, Sigma) was injected to 0.2mm
anterior, 2mm lateral from the right, and 3.5mm below the bregma at a rate of
0.15uL/min under anesthetized by 2% isoflurane.
The mice were scanned before, 1 day, 3 days, 7 days, and 14
days after ICH induction with a horizontal bore 3T Bruker BioSpec animal
scanner (Bruker, Germany), equipped with 40-mm volume transceiver coil for data
acquisition. Single slice CEST, T1 map and T2 map were acquired. An in-house
developed continuous-wave (CW) CEST sequence was used.10 The imaging parameters were as follows: TR = 6000ms; TE = 6ms; FOV = 20×20mm; matrix = 96×96; thickness
= 1.5mm; RARE factor = 32; B1 = 0.8μT and saturation time
(tsat) = 3s. Frequency offsets of the Z-spectrum included ±15ppm, ±10ppm,
±9ppm, and distributed between ±8ppm with 0.25ppm step size. Four S0
images at 200ppm were also acquired for data processing. For T1 map, it was
acquired using the built-in RARE sequence. For T2 map, it was
acquired using the built-in multi-slice multi echo (MSME) sequence.
A set of bovine serum albumin (BSA) phantom was designed to
study the iron effect to CEST. 8 different concentrations of ferrous iron (Iron(II)
sulfate heptahydrate, Sigma) were added to 10% BSA (Sigma). The phantom was scanned with the same sequences as the
animal study.
All data were analyzed with a custom-written Matlab (R2018b;
MathWorks) code. The APT and rNOE signal at 3.5ppm and -3.5ppm,
respectively, were acquired by subtracting the Z-spectrum with the Lorentzian-fitted water signal. AREX signal was acquired by following a published method
to correct the T1 relaxation effect.11,12Results and Discussion
In
order to study the paramagnetic iron effect to CEST, a phantom set was
designed. From Figure 1A, we could see that the iron change was inversely
proportional to both T1 and T2 values. Iron also had a suppression effect to CEST
(Fig. 1B), which resembled the T2 changes. However, the change was
insignificant at low iron content difference (below 1.25mM for rNOE and 2.5mM
for APT). It has been reported that the hematomal iron raised about 0.4mM on
day 3 and maximized at around 1.1mM on later time points.13 Since the change is within an
acceptable range, both rNOE and APT should be able to give resonable sensitivity
in ICH monitoring.
Figure 2 showed the result of a representative mouse brain
at specific time points. A hematoma could be seen on the caudate putamen after
ICH induction. The rNOE signal of the hematoma dropped gradually with time as
compare with the contralateral brain (Fig. 3A). The signal dropped around 17%
on day 1 and reached
a minimum on day 7, with around 37% difference. The signal
loss in hematoma on day 14 was comparable with day 7.
The APT (Fig. 3B) had similar trend, where the hematomal
signal decreased on day 1 and reached a minimum on day 3, with 30% and 47% reduction, respectively, as compare with
contralateral brain. After that, the signal slightly raised till day 14. APT correlated
with the pH 14 and amide proton signal.15 It is interesting to observe different trend in rNOE and APT over time in
hematoma. Immunohistological
study is underway to investigate the dominating contribution behind.
Conclusion
CEST has been applied to monitor the temporal changes of an
ICH brain and revealed the underlying molecular changes of the hematoma. The
significant drop of rNOE and APT contrast could indicate the underlying
mechanism, which further investigation is underway including histology. According
to our phantom and T2 maps, the iron content in the hematoma might not presence
at a high level, which will not attenuate the CEST contrast at 3T. Acknowledgements
We are grateful to receive funding support from the Research Grants Council of Hong Kong [11102218], the City University of Hong
Kong [7005210, 9680247, 9667198 and 6000660], and the National Natural Science
Foundation of China [81871409].References
- Zhu W, Gao Y, Chang CF, Wan JR, Zhu SS, Wang J. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 2014;9:1–11 doi: 10.1371/journal.pone.0097423.
- Righy C, T. Bozza M, F. Oliveira M, A. Bozza F. Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within? Curr. Neuropharmacol. 2015;14:392–402 doi: 10.2174/1570159x14666151230110058.
- Sun PZ, Zhou J, Sun W, Huang J, Zijl PCM Van. Detection of the ischemic penumbra using pH-weighted MRI. 2007:1129–1136 doi: 10.1038/sj.jcbfm.9600424.
- Zhao X, Wen Z, Huang F, et al. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn. Reson. Med. 2011;66:1033–1041 doi: 10.1002/mrm.22891.
- Sun PZ, Murata Y, Lu J, Wang X, Lo EH, Sorensen AG. Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn. Reson. Med. 2008;59:1175–1182 doi: 10.1002/mrm.21591.
- Wang M, Hong X, Chang CF, et al. Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI. Magn. Reson. Med. 2015;74:42–50 doi: 10.1002/mrm.25690.
- Xiong XY, Wang J, Qian ZM, Yang QW. Iron and Intracerebral Hemorrhage: From Mechanism to Translation. Transl. Stroke Res. 2014;5:429–441 doi: 10.1007/s12975-013-0317-7.
- Gilad AA, Van Laarhoven HWM, Mcmahon MT, et al. Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. Magn. Reson. Med. 2009;61:970–974 doi: 10.1002/mrm.21928.
- Li M, Li Z, Ren H, et al. Colony stimulating factor 1 receptor
inhibition eliminates microglia and attenuates brain injury after intracerebral
hemorrhage. J. Cereb. Blood Flow Metab. 2017;37:2383–2395 doi:
10.1177/0271678X16666551.
- Han X, Huang J, To AKW, et al. CEST MRI detectable liposomal hydrogels
for multiparametric monitoring in the brain at 3T. Theranostics 2020 doi:
10.7150/thno.40146..
- Zaiss M, Windschuh J, Paech D, et al. Relaxation-compensated CEST-MRI of the human brain at 7T: Unbiased insight into NOE and amide signal changes in human glioblastoma. Neuroimage 2015;112:180–188 doi: 10.1016/j.neuroimage.2015.02.040.
- Huang J, Han X, Chen L, Xu X, Xu J, Chan KWY. Relayed nuclear Overhauser enhancement imaging with magnetization transfer contrast suppression at 3 T. Magn. Reson. Med. 2020:1–14 doi: 10.1002/mrm.28433.
- Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and Iron-Handling Proteins in the Brain after Intracerebral Hemorrhage. Stroke 2003;34:2964–2969 doi: 10.1161/01.STR.0000103140.52838.45.
- Longo DL, Bartoli A, Consolino L, et al. In vivo imaging of tumor metabolism and acidosis by combining PET and MRI-CEST pH imaging. Cancer Res. 2016;76:6463–6470 doi: 10.1158/0008-5472.CAN-16-0825.
- Zhou J, Lal B, Wilson DA, Laterra J, Van Zijl PCM. Amide Proton Transfer (APT) Contrast for Imaging of Brain Tumors. Magn. Reson. Med. 2003;50:1120–1126 doi: 10.1002/mrm.10651.